PROCHLORPERAZINE MALEATE

PROCHLORPERAZINE MALEATE was reported 9343 times

PROCHLORPERAZINE MALEATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ABDOMINAL TRANSPOSITION 13 0.4815
1 NEUROLOGIC NEGLECT SYNDROME 21 0.0378
2 BLOOD PROLACTIN DECREASED 6 0.0343
3 CAROTID ARTERY THROMBOSIS 20 0.0236
4 ANAEMIA OF MALIGNANT DISEASE 6 0.0214
5 TYPE V HYPERLIPIDAEMIA 8 0.0165
6 AORTIC RUPTURE 6 0.0155
7 CONGENITAL CARDIOVASCULAR ANOMALY 13 0.0155
8 ADJUSTMENT DISORDER 18 0.0138
9 DEVICE MAINTENANCE ISSUE 6 0.0102
10 SPONDYLOARTHROPATHY 6 0.0100
11 BLADDER OBSTRUCTION 5 0.0097
12 MALIGNANT ASCITES 7 0.0091
13 HOSPICE CARE 89 0.0090
14 PERSONALITY DISORDER 23 0.0088
15 AORTIC CALCIFICATION 5 0.0086
16 TUMOUR PAIN 11 0.0083
17 STARVATION 6 0.0072
18 ESSENTIAL HYPERTENSION 13 0.0071
19 ANAEMIA OF CHRONIC DISEASE 6 0.0066
20 METASTASES TO ADRENALS 6 0.0065
21 ALOPECIA AREATA 10 0.0057
22 NON-SMALL CELL LUNG CANCER METASTATIC 5 0.0057
23 PANCREATIC CARCINOMA METASTATIC 16 0.0056
24 COLON CANCER METASTATIC 9 0.0056
25 CANCER PAIN 14 0.0055
26 PLASMA CELL MYELOMA RECURRENT 17 0.0052
27 GANGRENE 31 0.0051
28 FULL BLOOD COUNT DECREASED 103 0.0051
29 IMMUNOGLOBULINS DECREASED 7 0.0051
30 PNEUMONIA INFLUENZAL 6 0.0050
31 PSYCHOLOGICAL TRAUMA 43 0.0050
32 LUMBAR SPINAL STENOSIS 14 0.0048
33 HAIR COLOUR CHANGES 59 0.0047
34 PLASMA CELL MYELOMA REFRACTORY 6 0.0045
35 CARBOHYDRATE ANTIGEN 125 INCREASED 15 0.0044
36 HAIR DISORDER 35 0.0042
37 INFUSION SITE DISCHARGE 7 0.0040
38 TUMOUR MARKER INCREASED 19 0.0040
39 PLASMA CELL MYELOMA 154 0.0039
40 INTRA-ABDOMINAL FLUID COLLECTION 7 0.0039
41 MADAROSIS 45 0.0039
42 METASTATIC RENAL CELL CARCINOMA 7 0.0038
43 HAIR TEXTURE ABNORMAL 51 0.0038
44 PLASMACYTOMA 7 0.0038
45 METASTATIC NEOPLASM 16 0.0037
46 CARCINOEMBRYONIC ANTIGEN INCREASED 7 0.0036
47 DISCHARGE 5 0.0036
48 TASTE DISORDER 73 0.0036
49 HYPOGEUSIA 7 0.0036
50 ARTERIAL OCCLUSIVE DISEASE 28 0.0036
51 FAILURE TO THRIVE 18 0.0035
52 BLOOD MAGNESIUM DECREASED 28 0.0032
53 LOBAR PNEUMONIA 6 0.0032
54 FULL BLOOD COUNT ABNORMAL 34 0.0032
55 BLOOD IRON INCREASED 6 0.0032
56 METASTASES TO PERITONEUM 8 0.0032
57 DERMATOMYOSITIS 8 0.0032
58 RED BLOOD CELL COUNT DECREASED 87 0.0030
59 EMPYEMA 6 0.0030
60 WHITE BLOOD CELL DISORDER 8 0.0030
61 HYPOPHYSITIS 6 0.0030
62 MALIGNANT PLEURAL EFFUSION 5 0.0030
63 DERMATITIS ACNEIFORM 18 0.0030
64 RECURRENT CANCER 12 0.0029
65 RED CELL DISTRIBUTION WIDTH INCREASED 12 0.0029
66 HAEMATOLOGICAL INFECTION 7 0.0029
67 SENSORY LOSS 23 0.0029
68 CYTOPENIA 34 0.0028
69 HEMIPLEGIA 23 0.0028
70 PATHOLOGICAL FRACTURE 14 0.0028
71 ABDOMINAL INFECTION 7 0.0027
72 OESOPHAGEAL SPASM 5 0.0027
73 BILE DUCT OBSTRUCTION 5 0.0026
74 PROTEIN TOTAL INCREASED 7 0.0026
75 LYMPHOEDEMA 18 0.0026
76 PLATELET COUNT DECREASED 277 0.0026
77 ATELECTASIS 25 0.0026
78 INVASIVE DUCTAL BREAST CARCINOMA 7 0.0026
79 METASTASES TO LIVER 45 0.0026
80 FOREIGN BODY IN THROAT 8 0.0025
81 HYPERKERATOSIS 14 0.0025
82 BONE LESION 9 0.0025
83 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 58 0.0025
84 NEUROPATHY PERIPHERAL 235 0.0025
85 WHITE BLOOD CELL COUNT DECREASED 266 0.0025
86 INFUSION SITE HAEMORRHAGE 8 0.0024
87 BLOOD POTASSIUM DECREASED 73 0.0024
88 COMPRESSION FRACTURE 13 0.0024
89 CHOLANGITIS 15 0.0024
90 HAEMOTHORAX 7 0.0024
91 HEPATIC ENZYME ABNORMAL 12 0.0024
92 LUMBAR VERTEBRAL FRACTURE 11 0.0024
93 CATHETER SITE HAEMORRHAGE 6 0.0024
94 MULTIPLE MYELOMA 11 0.0024
95 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 9 0.0024
96 MOTOR DYSFUNCTION 24 0.0024
97 EATING DISORDER 50 0.0023
98 LACTOSE INTOLERANCE 6 0.0023
99 STOMATITIS 142 0.0023
100 DEHYDRATION 312 0.0023
101 DISEASE PROGRESSION 276 0.0023
102 OCULOGYRIC CRISIS 5 0.0023
103 ONYCHOCLASIS 16 0.0023
104 BONE MARROW DISORDER 7 0.0023
105 INFUSION SITE BRUISING 5 0.0023
106 HEPATIC LESION 10 0.0023
107 NAIL DISCOLOURATION 9 0.0023
108 OESOPHAGITIS 25 0.0023
109 DIASTOLIC DYSFUNCTION 7 0.0023
110 DECREASED APPETITE 526 0.0023
111 METASTASES TO MENINGES 5 0.0022
112 HAEMOGLOBIN INCREASED 10 0.0022
113 BLOOD COUNT ABNORMAL 33 0.0022
114 SINUS CONGESTION 29 0.0021
115 LABORATORY TEST ABNORMAL 63 0.0021
116 SMALL INTESTINAL OBSTRUCTION 26 0.0021
117 COLORECTAL CANCER METASTATIC 5 0.0021
118 METASTASES TO SPINE 7 0.0021
119 OESOPHAGEAL ULCER 8 0.0021
120 AFFECT LABILITY 20 0.0021
121 METASTASES TO LYMPH NODES 14 0.0021
122 SPINAL CORD COMPRESSION 8 0.0021
123 CONSTIPATION 444 0.0020
124 SKIN HAEMORRHAGE 30 0.0020
125 SINUS DISORDER 40 0.0020
126 SQUAMOUS CELL CARCINOMA OF SKIN 12 0.0020
127 PLATELET COUNT ABNORMAL 12 0.0020
128 RECTAL CANCER 6 0.0020
129 HYPOMAGNESAEMIA 27 0.0019
130 COORDINATION ABNORMAL 27 0.0019
131 PERFORMANCE STATUS DECREASED 9 0.0019
132 HAEMATOCRIT DECREASED 38 0.0019
133 FOOD INTOLERANCE 7 0.0019
134 SEASONAL ALLERGY 27 0.0019
135 GASTROINTESTINAL STROMAL TUMOUR 5 0.0019
136 MUSCLE SPASTICITY 23 0.0019
137 METASTASES TO CENTRAL NERVOUS SYSTEM 24 0.0019
138 FEBRILE NEUTROPENIA 123 0.0019
139 BACTERAEMIA 22 0.0019
140 BRAIN FOG 29 0.0018
141 STAPHYLOCOCCAL BACTERAEMIA 8 0.0018
142 NEOPLASM PROGRESSION 64 0.0018
143 HAEMOGLOBIN DECREASED 188 0.0018
144 RESPIRATORY TRACT CONGESTION 29 0.0018
145 TOOTH INFECTION 24 0.0018
146 METASTASES TO LUNG 21 0.0018
147 ORAL INFECTION 7 0.0018
148 INFUSION SITE PAIN 23 0.0018
149 PROSTATOMEGALY 7 0.0018
150 TONGUE ULCERATION 6 0.0018
151 CEREBRAL ATROPHY 7 0.0018
152 PANCYTOPENIA 98 0.0018
153 DYSPNOEA EXERTIONAL 66 0.0018
154 COLON CANCER 26 0.0017
155 ORAL PAIN 39 0.0017
156 LARGE INTESTINE POLYP 12 0.0017
157 ENTEROCOLITIS 10 0.0017
158 MALIGNANT NEOPLASM PROGRESSION 177 0.0017
159 FEEDING DISORDER 35 0.0017
160 WHITE BLOOD CELL COUNT ABNORMAL 11 0.0017
161 RENAL FUNCTION TEST ABNORMAL 8 0.0017
162 NAIL DISORDER 15 0.0017
163 FATIGUE 1330 0.0017
164 ASCITES 50 0.0017
165 EUGLYCAEMIC DIABETIC KETOACIDOSIS 7 0.0017
166 NAUSEA 1334 0.0017
167 HYPOPHAGIA 43 0.0017
168 HYPOALBUMINAEMIA 13 0.0017
169 CENTRAL VENOUS CATHETERISATION 5 0.0017
170 METASTASES TO BONE 27 0.0016
171 NEUTROPHIL COUNT DECREASED 67 0.0016
172 HYPERSOMNIA 47 0.0016
173 HEPATIC PAIN 7 0.0016
174 BLOOD TEST ABNORMAL 23 0.0016
175 DUODENITIS 5 0.0016
176 PORTAL HYPERTENSION 5 0.0016
177 THROMBOCYTOPENIA 181 0.0016
178 ABDOMINAL TENDERNESS 8 0.0016
179 BLOOD CREATININE DECREASED 5 0.0016
180 PROTEIN TOTAL DECREASED 6 0.0016
181 PERIORBITAL SWELLING 9 0.0016
182 TUMOUR LYSIS SYNDROME 14 0.0016
183 HICCUPS 13 0.0016
184 BILE DUCT STONE 5 0.0016
185 PULMONARY THROMBOSIS 17 0.0016
186 DIARRHOEA 1006 0.0016
187 IRON DEFICIENCY 7 0.0016
188 MUSCULOSKELETAL CHEST PAIN 24 0.0015
189 PNEUMONITIS 42 0.0015
190 RHINOVIRUS INFECTION 6 0.0015
191 TENDERNESS 16 0.0015
192 ABDOMINAL HERNIA 7 0.0015
193 PETECHIAE 16 0.0015
194 HEPATIC NEOPLASM 5 0.0015
195 DISEASE COMPLICATION 7 0.0015
196 NEPHROGENIC ANAEMIA 7 0.0015
197 ARTHRITIS INFECTIVE 7 0.0015
198 CLOSTRIDIUM DIFFICILE COLITIS 16 0.0015
199 ANXIETY DISORDER 5 0.0015
200 ASTHENIA 561 0.0015
201 HAEMORRHOIDS 29 0.0015
202 SKIN ABRASION 7 0.0015
203 SPINAL OSTEOARTHRITIS 13 0.0015
204 ACUTE MYELOID LEUKAEMIA 23 0.0015
205 NEUTROPENIA 200 0.0015
206 BONE PAIN 86 0.0015
207 ABNORMAL LOSS OF WEIGHT 10 0.0015
208 HYPERCALCAEMIA 18 0.0015
209 INTERNATIONAL NORMALISED RATIO ABNORMAL 5 0.0015
210 LEFT VENTRICULAR FAILURE 5 0.0015
211 SPINAL COMPRESSION FRACTURE 12 0.0014
212 HYPERBILIRUBINAEMIA 15 0.0014
213 DIZZINESS POSTURAL 14 0.0014
214 TOOTH DISORDER 32 0.0014
215 BLOOD SODIUM DECREASED 27 0.0014
216 TRANSFUSION 15 0.0014
217 HYPOKALAEMIA 66 0.0014
218 ONYCHOMADESIS 6 0.0014
219 NIGHT SWEATS 46 0.0014
220 VOMITING 671 0.0014
221 PANCREATIC DISORDER 7 0.0014
222 TONGUE DISCOMFORT 6 0.0014
223 PELVIC FRACTURE 11 0.0014
224 ESCHERICHIA URINARY TRACT INFECTION 6 0.0014
225 AGEUSIA 35 0.0014
226 SKIN ATROPHY 8 0.0014
227 DYSLIPIDAEMIA 7 0.0014
228 MONOCYTE COUNT INCREASED 5 0.0014
229 LIVER FUNCTION TEST ABNORMAL 40 0.0014
230 SKIN WARM 8 0.0014
231 MENTAL STATUS CHANGES 38 0.0014
232 PHLEBITIS 7 0.0014
233 DEVICE RELATED INFECTION 21 0.0014
234 RETCHING 29 0.0014
235 PERIPHERAL VASCULAR DISORDER 7 0.0014
236 HEMIPARESIS 23 0.0014
237 ABDOMINAL ABSCESS 6 0.0014
238 SENSITIVE SKIN 10 0.0014
239 ILEUS PARALYTIC 6 0.0013
240 CARDIAC DYSFUNCTION 5 0.0013
241 PULMONARY MASS 20 0.0013
242 PERICARDIAL EFFUSION 31 0.0013
243 MALNUTRITION 15 0.0013
244 ANGINA PECTORIS 38 0.0013
245 VASCULAR DEVICE INFECTION 6 0.0013
246 CHEMOTHERAPY 5 0.0013
247 BLOOD THYROID STIMULATING HORMONE DECREASED 6 0.0013
248 DYSPHONIA 77 0.0013
249 AORTIC ANEURYSM 10 0.0013
250 TROPONIN INCREASED 10 0.0013
251 EAR DISORDER 6 0.0013
252 BOWEL MOVEMENT IRREGULARITY 10 0.0013
253 LIPASE INCREASED 10 0.0013
254 DYSURIA 48 0.0013
255 GINGIVAL DISORDER 5 0.0013
256 OESOPHAGEAL DISORDER 5 0.0013
257 PLEURAL EFFUSION 79 0.0013
258 INTERVERTEBRAL DISC DEGENERATION 12 0.0013
259 ANAEMIA 247 0.0013
260 SNEEZING 29 0.0013
261 ELECTROLYTE IMBALANCE 15 0.0013
262 CYSTITIS 41 0.0013
263 CLOSTRIDIUM DIFFICILE INFECTION 28 0.0013
264 YELLOW SKIN 6 0.0013
265 DUODENAL ULCER 9 0.0013
266 URINARY TRACT INFECTION 217 0.0013
267 PRODUCT DOSE OMISSION IN ERROR 36 0.0013
268 THROMBOSIS 102 0.0013
269 SPINAL DISORDER 12 0.0013
270 OESOPHAGEAL PAIN 5 0.0013
271 PULSE ABSENT 6 0.0013
272 BLOOD BILIRUBIN INCREASED 34 0.0013
273 GINGIVAL PAIN 10 0.0013
274 IMPAIRED QUALITY OF LIFE 18 0.0013
275 OSTEOPENIA 19 0.0013
276 GRAFT VERSUS HOST DISEASE 9 0.0013
277 IMMUNOSUPPRESSION 11 0.0012
278 LUNG INFILTRATION 11 0.0012
279 PROCTALGIA 8 0.0012
280 WEIGHT FLUCTUATION 13 0.0012
281 SKIN ULCER 32 0.0012
282 RHINORRHOEA 80 0.0012
283 BLOOD PRESSURE INCREASED 189 0.0012
284 DEEP VEIN THROMBOSIS 80 0.0012
285 HORMONE LEVEL ABNORMAL 6 0.0012
286 DECUBITUS ULCER 10 0.0012
287 CATARACT 73 0.0012
288 DYSPHAGIA 116 0.0012
289 WEIGHT DECREASED 341 0.0012
290 DYSPEPSIA 120 0.0012
291 PNEUMONIA 394 0.0012
292 LEUKOCYTOSIS 22 0.0012
293 WALKING AID USER 8 0.0012
294 BLOOD URIC ACID INCREASED 7 0.0012
295 BREAST CANCER METASTATIC 13 0.0012
296 PROTEIN URINE PRESENT 6 0.0012
297 SECOND PRIMARY MALIGNANCY 10 0.0012
298 SEPSIS 134 0.0012
299 PNEUMOTHORAX 19 0.0012
300 MENINGITIS 8 0.0012
301 BRAIN NEOPLASM 11 0.0012
302 HYPOVOLAEMIA 7 0.0012
303 TERMINAL STATE 8 0.0012
304 EPISTAXIS 89 0.0012
305 LYMPHOCYTE COUNT DECREASED 21 0.0012
306 ASPIRATION 13 0.0012
307 POSTOPERATIVE WOUND INFECTION 8 0.0012
308 AMMONIA INCREASED 6 0.0012
309 POOR PERIPHERAL CIRCULATION 5 0.0012
310 FLANK PAIN 11 0.0012
311 DYSGEUSIA 87 0.0012
312 DYSARTHRIA 44 0.0012
313 PERIPHERAL SWELLING 180 0.0012
314 ECCHYMOSIS 8 0.0012
315 ALOPECIA 229 0.0012
316 LEUKAEMIA 11 0.0012
317 PROSTATIC SPECIFIC ANTIGEN INCREASED 16 0.0012
318 HAIR GROWTH ABNORMAL 8 0.0012
319 MASS 16 0.0011
320 DIVERTICULUM INTESTINAL 5 0.0011
321 COLITIS 43 0.0011
322 GINGIVAL SWELLING 5 0.0011
323 ANORECTAL DISCOMFORT 6 0.0011
324 ATRIAL FLUTTER 9 0.0011
325 CANDIDA INFECTION 19 0.0011
326 DELIRIUM 39 0.0011
327 BODY HEIGHT DECREASED 12 0.0011
328 GASTROINTESTINAL MOTILITY DISORDER 6 0.0011
329 HYPONATRAEMIA 63 0.0011
330 INFUSION SITE SWELLING 7 0.0011
331 OROPHARYNGEAL DISCOMFORT 10 0.0011
332 HAEMATEMESIS 28 0.0011
333 SKIN LACERATION 12 0.0011
334 HYPERAESTHESIA 9 0.0011
335 APHASIA 33 0.0011
336 CELLULITIS 55 0.0011
337 ORAL DISORDER 8 0.0011
338 CHOLECYSTITIS 13 0.0011
339 PHOTOSENSITIVITY REACTION 18 0.0011
340 BLOOD PRESSURE DIASTOLIC INCREASED 5 0.0011
341 IRON DEFICIENCY ANAEMIA 10 0.0011
342 CHRONIC MYELOID LEUKAEMIA 5 0.0011
343 HYPOPHOSPHATAEMIA 8 0.0011
344 PRODUCT DISTRIBUTION ISSUE 10 0.0011
345 ADRENAL INSUFFICIENCY 13 0.0011
346 NOCTURIA 13 0.0011
347 KIDNEY INFECTION 21 0.0011
348 SKIN INFECTION 12 0.0011
349 INFUSION SITE ERYTHEMA 9 0.0011
350 TEMPERATURE INTOLERANCE 11 0.0011
351 DISSEMINATED INTRAVASCULAR COAGULATION 15 0.0011
352 EYE INFECTION 12 0.0011
353 GOUT 19 0.0011
354 MUSCULAR WEAKNESS 120 0.0011
355 GASTROENTERITIS VIRAL 19 0.0011
356 PRODUCTIVE COUGH 50 0.0010
357 BLOOD POTASSIUM INCREASED 17 0.0010
358 BLOOD ALKALINE PHOSPHATASE INCREASED 26 0.0010
359 LYMPHADENOPATHY 37 0.0010
360 NON-SMALL CELL LUNG CANCER 5 0.0010
361 EXERCISE TOLERANCE DECREASED 6 0.0010
362 RENAL FAILURE CHRONIC 8 0.0010
363 MUSCLE STRAIN 9 0.0010
364 MYELODYSPLASTIC SYNDROME 15 0.0010
365 HUMERUS FRACTURE 5 0.0010
366 ORTHOSTATIC HYPOTENSION 18 0.0010
367 MUCOSAL INFLAMMATION 27 0.0010
368 BACK PAIN 239 0.0010
369 GINGIVAL BLEEDING 14 0.0010
370 HAEMORRHOIDAL HAEMORRHAGE 5 0.0010
371 FEELING OF BODY TEMPERATURE CHANGE 6 0.0010
372 HYPOXIA 36 0.0010
373 ENCEPHALOPATHY 25 0.0010
374 RASH PRURITIC 55 0.0010
375 BLOOD ALBUMIN DECREASED 8 0.0010
376 LARGE INTESTINE PERFORATION 7 0.0010
377 MYOCLONUS 12 0.0010
378 BLOOD PRESSURE ABNORMAL 20 0.0010
379 HIATUS HERNIA 13 0.0010
380 BLISTER 56 0.0010
381 ABDOMINAL DISCOMFORT 167 0.0010
382 STENT PLACEMENT 8 0.0010
383 ACUTE RESPIRATORY FAILURE 19 0.0010
384 FLATULENCE 56 0.0010
385 DIVERTICULUM 7 0.0010
386 CONFUSIONAL STATE 159 0.0010
387 GLOSSODYNIA 22 0.0010
388 TOOTH ABSCESS 10 0.0010
389 BLOOD CALCIUM DECREASED 11 0.0010
390 BLOOD THYROID STIMULATING HORMONE INCREASED 9 0.0010
391 ENDOCARDITIS 5 0.0010
392 ESCHERICHIA INFECTION 8 0.0010
393 PIGMENTATION DISORDER 6 0.0010
394 HYPOCALCAEMIA 18 0.0010
395 LOCALISED INFECTION 23 0.0010
396 PHOTOPSIA 6 0.0009
397 DRY MOUTH 77 0.0009
398 BLOOD PRESSURE DIASTOLIC DECREASED 7 0.0009
399 BLOOD URINE PRESENT 18 0.0009
400 INCONTINENCE 10 0.0009
401 GASTROOESOPHAGEAL REFLUX DISEASE 76 0.0009
402 OEDEMA PERIPHERAL 115 0.0009
403 IMMUNODEFICIENCY 14 0.0009
404 ENTERITIS 6 0.0009
405 VITAMIN D DECREASED 8 0.0009
406 ORAL DISCOMFORT 13 0.0009
407 HYDRONEPHROSIS 7 0.0009
408 FOOD POISONING 5 0.0009
409 GASTRIC DISORDER 32 0.0009
410 PRODUCT SIZE ISSUE 5 0.0009
411 MUSCULOSKELETAL DISCOMFORT 16 0.0009
412 HOT FLUSH 70 0.0009
413 PYREXIA 321 0.0009
414 SINUSITIS 95 0.0009
415 DECREASED ACTIVITY 10 0.0009
416 CARDIAC MURMUR 8 0.0009
417 SKIN EXFOLIATION 78 0.0009
418 ATRIAL FIBRILLATION 90 0.0009
419 CHEILITIS 5 0.0009
420 RIB FRACTURE 19 0.0009
421 SKIN FISSURES 18 0.0009
422 PULMONARY EMBOLISM 87 0.0009
423 MATERNAL DRUGS AFFECTING FOETUS 7 0.0009
424 PULMONARY CONGESTION 12 0.0009
425 DIFFUSE LARGE B-CELL LYMPHOMA 7 0.0009
426 THYROID DISORDER 14 0.0009
427 INFLUENZA 101 0.0009
428 APPETITE DISORDER 6 0.0009
429 GASTRIC ULCER HAEMORRHAGE 5 0.0009
430 EJECTION FRACTION DECREASED 14 0.0009
431 SALIVARY HYPERSECRETION 9 0.0009
432 SKIN MASS 6 0.0009
433 NECROSIS 5 0.0009
434 MULTIPLE ALLERGIES 7 0.0009
435 COUGH 250 0.0009
436 GENERALISED OEDEMA 11 0.0009
437 RASH GENERALISED 23 0.0009
438 UPPER RESPIRATORY TRACT INFECTION 41 0.0009
439 DRY THROAT 9 0.0009
440 FLUID RETENTION 45 0.0009
441 NEOPLASM MALIGNANT 59 0.0009
442 TOOTHACHE 16 0.0009
443 MUSCLE SPASMS 162 0.0009
444 IMPAIRED GASTRIC EMPTYING 12 0.0009
445 PERONEAL NERVE PALSY 5 0.0009
446 NEUTROPHIL COUNT INCREASED 9 0.0009
447 EAR PAIN 17 0.0009
448 GASTRITIS 23 0.0009
449 BLOOD DISORDER 7 0.0009
450 RASH 380 0.0009
451 PNEUMONIA BACTERIAL 8 0.0009
452 INCREASED TENDENCY TO BRUISE 8 0.0009
453 RHINITIS 7 0.0009
454 UROSEPSIS 8 0.0009
455 VENTRICULAR EXTRASYSTOLES 9 0.0009
456 HYPOTENSION 173 0.0009
457 LETHARGY 49 0.0009
458 INSURANCE ISSUE 13 0.0008
459 INTESTINAL OBSTRUCTION 32 0.0008
460 ASPARTATE AMINOTRANSFERASE INCREASED 45 0.0008
461 PLEURISY 5 0.0008
462 GASTRIC ULCER 16 0.0008
463 CHROMATURIA 19 0.0008
464 MUSCULOSKELETAL PAIN 44 0.0008
465 SUBDURAL HAEMATOMA 12 0.0008
466 ABDOMINAL PAIN 195 0.0008
467 RESPIRATORY FAILURE 61 0.0008
468 HEPATIC ENZYME INCREASED 57 0.0008
469 BLOOD UREA INCREASED 14 0.0008
470 WHITE BLOOD CELL COUNT INCREASED 32 0.0008
471 ABDOMINAL DISTENSION 87 0.0008
472 BLOOD PRESSURE FLUCTUATION 20 0.0008
473 DRY SKIN 111 0.0008
474 LACRIMATION INCREASED 25 0.0008
475 SKIN DISCOLOURATION 38 0.0008
476 GASTROINTESTINAL DISORDER 74 0.0008
477 DEATH 711 0.0008
478 NECK PAIN 46 0.0008
479 PRODUCT DOSE OMISSION ISSUE 242 0.0008
480 INGUINAL HERNIA 5 0.0008
481 PARKINSONISM 8 0.0008
482 CONTUSION 78 0.0008
483 INTENTIONAL DOSE OMISSION 23 0.0008
484 AKATHISIA 11 0.0008
485 ILEUS 10 0.0008
486 PULMONARY OEDEMA 36 0.0008
487 MUSCLE TIGHTNESS 13 0.0008
488 SKIN LESION 22 0.0008
489 NEPHROPATHY TOXIC 9 0.0008
490 INFECTION 116 0.0008
491 RENAL FAILURE ACUTE 34 0.0008
492 HYPERKALAEMIA 28 0.0008
493 NASAL DRYNESS 5 0.0008
494 GROIN PAIN 7 0.0008
495 HEART RATE IRREGULAR 18 0.0008
496 PAROSMIA 6 0.0008
497 CHOLELITHIASIS 26 0.0008
498 POOR QUALITY SLEEP 17 0.0008
499 DERMATITIS CONTACT 9 0.0008
500 APHONIA 11 0.0008
501 INTERNAL HAEMORRHAGE 9 0.0008
502 FALL 262 0.0008
503 GALLBLADDER DISORDER 14 0.0008
504 FACIAL PAIN 7 0.0008
505 THIRST 14 0.0008
506 HAEMOGLOBIN ABNORMAL 5 0.0008
507 PAIN IN JAW 22 0.0008
508 ANOREXIA 10 0.0008
509 HERNIA 15 0.0008
510 CONCUSSION 6 0.0008
511 RENAL DISORDER 36 0.0008
512 INCOHERENT 5 0.0008
513 CHEST DISCOMFORT 79 0.0008
514 HERPES SIMPLEX 5 0.0008
515 BASAL CELL CARCINOMA 12 0.0008
516 SPLENOMEGALY 9 0.0008
517 BONE DISORDER 14 0.0008
518 ILLNESS 79 0.0008
519 BLOOD CREATININE INCREASED 50 0.0008
520 ARTHRITIS 60 0.0008
521 PAIN IN EXTREMITY 224 0.0008
522 NASOPHARYNGITIS 140 0.0008
523 ORAL CANDIDIASIS 10 0.0008
524 BLOOD IRON DECREASED 9 0.0008
525 DIVERTICULITIS 21 0.0008
526 RENAL CYST 6 0.0008
527 RENAL PAIN 8 0.0008
528 ADVERSE REACTION 10 0.0008
529 GASTROENTERITIS 11 0.0008
530 HAEMOPTYSIS 21 0.0008
531 PRESCRIBED UNDERDOSE 15 0.0008
532 HEPATIC STEATOSIS 14 0.0008
533 HYPOAESTHESIA 112 0.0007
534 ABDOMINAL PAIN UPPER 154 0.0007
535 HIP FRACTURE 24 0.0007
536 HEREDITARY ANGIOEDEMA 8 0.0007
537 QUALITY OF LIFE DECREASED 10 0.0007
538 LIVER FUNCTION TEST INCREASED 16 0.0007
539 RASH MACULAR 26 0.0007
540 OEDEMA 40 0.0007
541 PARAESTHESIA 116 0.0007
542 HEART RATE INCREASED 73 0.0007
543 INTERVERTEBRAL DISC PROTRUSION 16 0.0007
544 DISORIENTATION 29 0.0007
545 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
546 WOUND INFECTION 8 0.0007
547 GASTROINTESTINAL HAEMORRHAGE 61 0.0007
548 BRONCHITIS 54 0.0007
549 UPPER-AIRWAY COUGH SYNDROME 6 0.0007
550 ACUTE CORONARY SYNDROME 6 0.0007
551 CHEST PAIN 134 0.0007
552 MYALGIA 123 0.0007
553 ENCEPHALITIS 5 0.0007
554 INSOMNIA 192 0.0007
555 COAGULOPATHY 12 0.0007
556 ALANINE AMINOTRANSFERASE INCREASED 44 0.0007
557 RASH PAPULAR 16 0.0007
558 COELIAC DISEASE 7 0.0007
559 HYPERTENSION 151 0.0007
560 ADVERSE DRUG REACTION 64 0.0007
561 BRAIN OEDEMA 9 0.0007
562 HEPATOMEGALY 7 0.0007
563 VITREOUS FLOATERS 7 0.0007
564 URINARY INCONTINENCE 21 0.0007
565 DYSPNOEA 399 0.0007
566 SINUS TACHYCARDIA 10 0.0007
567 FACIAL PARALYSIS 6 0.0007
568 UPPER LIMB FRACTURE 14 0.0007
569 HAEMATURIA 24 0.0007
570 ROTATOR CUFF SYNDROME 9 0.0007
571 METASTASIS 5 0.0007
572 MICTURITION URGENCY 8 0.0007
573 LEUKOPENIA 35 0.0007
574 NEOPLASM 8 0.0007
575 DIZZINESS 347 0.0007
576 NODULE 9 0.0007
577 FAECES SOFT 5 0.0007
578 URINE OUTPUT DECREASED 6 0.0007
579 JOINT STIFFNESS 18 0.0007
580 RENAL FAILURE 91 0.0007
581 INTENTIONAL UNDERDOSE 5 0.0007
582 BLOOD CALCIUM INCREASED 6 0.0007
583 BLOOD PRESSURE DECREASED 45 0.0007
584 LOWER LIMB FRACTURE 13 0.0007
585 POOR VENOUS ACCESS 7 0.0007
586 CEREBRAL DISORDER 5 0.0007
587 ARTHRALGIA 281 0.0007
588 PAIN 413 0.0007
589 POLLAKIURIA 28 0.0007
590 BALANCE DISORDER 58 0.0007
591 DYSTONIA 13 0.0007
592 HAEMOLYTIC ANAEMIA 6 0.0007
593 MALAISE 293 0.0007
594 CHILLS 78 0.0007
595 TREMOR 110 0.0007
596 DRUG TOXICITY 9 0.0007
597 FUNGAL INFECTION 22 0.0007
598 NEURALGIA 16 0.0007
599 PANCREATIC CARCINOMA 19 0.0007
600 INFLUENZA LIKE ILLNESS 54 0.0007
601 PERIPHERAL COLDNESS 9 0.0007
602 MEMORY IMPAIRMENT 90 0.0007
603 CARDIOMEGALY 8 0.0006
604 SKIN CANCER 14 0.0006
605 SPINAL OPERATION 8 0.0006
606 OROPHARYNGEAL PAIN 60 0.0006
607 CYTOKINE RELEASE SYNDROME 13 0.0006
608 FEELING COLD 18 0.0006
609 LIMB DISCOMFORT 20 0.0006
610 SOMNOLENCE 130 0.0006
611 EYE SWELLING 24 0.0006
612 ACUTE MYOCARDIAL INFARCTION 19 0.0006
613 LUNG INFECTION 10 0.0006
614 HEPATIC ENCEPHALOPATHY 6 0.0006
615 TOOTH EXTRACTION 8 0.0006
616 CARPAL TUNNEL SYNDROME 9 0.0006
617 SCAR 11 0.0006
618 VISION BLURRED 88 0.0006
619 EAR INFECTION 17 0.0006
620 ELECTROCARDIOGRAM ABNORMAL 5 0.0006
621 OSTEOARTHRITIS 27 0.0006
622 MULTI-ORGAN FAILURE 11 0.0006
623 DENTAL CARIES 7 0.0006
624 DRUG INTOLERANCE 61 0.0006
625 PROTEINURIA 12 0.0006
626 BLOOD LACTATE DEHYDROGENASE INCREASED 10 0.0006
627 NERVE INJURY 7 0.0006
628 ULCER 10 0.0006
629 OBESITY 10 0.0006
630 LIMB INJURY 17 0.0006
631 COVID-19 109 0.0006
632 COMPLICATION ASSOCIATED WITH DEVICE 9 0.0006
633 SYNCOPE 62 0.0006
634 MIGRAINE 59 0.0006
635 SWELLING FACE 40 0.0006
636 RESPIRATORY TRACT INFECTION 16 0.0006
637 PLATELET COUNT INCREASED 8 0.0006
638 ANXIETY 174 0.0006
639 THERAPY CHANGE 6 0.0006
640 HERPES ZOSTER 35 0.0006
641 IMMUNE SYSTEM DISORDER 8 0.0006
642 LIGAMENT SPRAIN 6 0.0006
643 PALPITATIONS 71 0.0006
644 EMBOLISM 5 0.0006
645 VIRAL INFECTION 20 0.0006
646 GAIT DISTURBANCE 115 0.0006
647 PNEUMONIA ASPIRATION 15 0.0006
648 HEADACHE 376 0.0006
649 COGNITIVE DISORDER 28 0.0006
650 FAECES DISCOLOURED 13 0.0006
651 URINARY RETENTION 20 0.0006
652 INTERSTITIAL LUNG DISEASE 29 0.0006
653 HOSPITALISATION 92 0.0006
654 PNEUMOCYSTIS JIROVECII PNEUMONIA 6 0.0006
655 SPINAL PAIN 7 0.0006
656 HYPOAESTHESIA ORAL 9 0.0006
657 JAUNDICE 16 0.0006
658 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 31 0.0006
659 CONJUNCTIVITIS 11 0.0006
660 SPEECH DISORDER 31 0.0006
661 VERTIGO 36 0.0006
662 EYELID PTOSIS 6 0.0006
663 TACHYPNOEA 8 0.0006
664 SWELLING 55 0.0006
665 OXYGEN SATURATION DECREASED 33 0.0006
666 MACULAR DEGENERATION 7 0.0006
667 HYPERLIPIDAEMIA 7 0.0006
668 EAR DISCOMFORT 6 0.0006
669 RASH MACULO-PAPULAR 13 0.0006
670 PSEUDOMONAS INFECTION 5 0.0006
671 LYMPHOMA 9 0.0006
672 SLEEP DISORDER 41 0.0006
673 RESPIRATORY DISTRESS 16 0.0006
674 STAPHYLOCOCCAL INFECTION 19 0.0006
675 PRESYNCOPE 14 0.0006
676 INCREASED APPETITE 11 0.0006
677 DERMATITIS 12 0.0006
678 ERUCTATION 11 0.0006
679 DEVICE OCCLUSION 8 0.0006
680 JOINT DISLOCATION 6 0.0006
681 CYST 7 0.0006
682 DIALYSIS 8 0.0006
683 HYPOTHYROIDISM 18 0.0006
684 JOINT SWELLING 68 0.0006
685 TRANSIENT ISCHAEMIC ATTACK 19 0.0006
686 BREAST PAIN 6 0.0006
687 ACUTE KIDNEY INJURY 86 0.0006
688 HAEMATOCHEZIA 31 0.0006
689 DRY EYE 28 0.0006
690 HYPOACUSIS 24 0.0006
691 PHARYNGITIS STREPTOCOCCAL 6 0.0006
692 OFF LABEL USE 485 0.0006
693 HYPERTHYROIDISM 8 0.0006
694 OSTEOMYELITIS 10 0.0006
695 SEPTIC SHOCK 24 0.0006
696 LUNG DISORDER 27 0.0006
697 LIP DRY 5 0.0005
698 RESTLESS LEGS SYNDROME 10 0.0005
699 HYPERGLYCAEMIA 20 0.0005
700 PANCREATITIS 29 0.0005
701 DYSSTASIA 16 0.0005
702 FEELING ABNORMAL 131 0.0005
703 TOOTH FRACTURE 6 0.0005
704 UNRESPONSIVE TO STIMULI 14 0.0005
705 BONE MARROW FAILURE 11 0.0005
706 SKIN DISORDER 18 0.0005
707 NEPHROPATHY 5 0.0005
708 DEAFNESS 14 0.0005
709 CARDIAC FAILURE CONGESTIVE 43 0.0005
710 LUNG NEOPLASM MALIGNANT 22 0.0005
711 OCULAR DISCOMFORT 6 0.0005
712 PRURITUS 205 0.0005
713 BEDRIDDEN 7 0.0005
714 HEPATIC CIRRHOSIS 10 0.0005
715 PULMONARY HYPERTENSION 11 0.0005
716 INTERNATIONAL NORMALISED RATIO INCREASED 15 0.0005
717 CEREBROVASCULAR ACCIDENT 89 0.0005
718 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 5 0.0005
719 MALIGNANT MELANOMA 7 0.0005
720 POST PROCEDURAL COMPLICATION 10 0.0005
721 THERAPY INTERRUPTED 37 0.0005
722 UNEVALUABLE EVENT 39 0.0005
723 DELUSION 8 0.0005
724 DEPRESSION 117 0.0005
725 BURNING SENSATION 36 0.0005
726 THROAT IRRITATION 23 0.0005
727 CORONARY ARTERY OCCLUSION 7 0.0005
728 BLOOD TRIGLYCERIDES INCREASED 9 0.0005
729 COVID-19 PNEUMONIA 6 0.0005
730 PRODUCT USE COMPLAINT 8 0.0005
731 PRODUCT DOSE OMISSION 33 0.0005
732 RASH ERYTHEMATOUS 24 0.0005
733 HAEMATOMA 13 0.0005
734 WOUND 14 0.0005
735 DIPLOPIA 13 0.0005
736 MELAENA 11 0.0005
737 SPINAL FRACTURE 10 0.0005
738 LIVER DISORDER 22 0.0005
739 EMPHYSEMA 5 0.0005
740 TRANSAMINASES INCREASED 11 0.0005
741 BURSITIS 6 0.0005
742 BLOOD CHOLESTEROL INCREASED 23 0.0005
743 AMNESIA 32 0.0005
744 RESTLESSNESS 18 0.0005
745 DEPRESSED MOOD 26 0.0005
746 LOSS OF CONSCIOUSNESS 63 0.0005
747 HALLUCINATION 37 0.0005
748 OSTEOPOROSIS 20 0.0005
749 FEMUR FRACTURE 15 0.0005
750 THINKING ABNORMAL 9 0.0005
751 DISTURBANCE IN ATTENTION 26 0.0005
752 PSYCHOMOTOR HYPERACTIVITY 8 0.0005
753 TUBULOINTERSTITIAL NEPHRITIS 9 0.0005
754 NASAL CONGESTION 28 0.0005
755 PERICARDITIS 8 0.0005
756 CARDIOMYOPATHY 7 0.0005
757 TACHYCARDIA 42 0.0005
758 ABNORMAL DREAMS 13 0.0005
759 VISUAL IMPAIRMENT 58 0.0005
760 RESPIRATORY DISORDER 14 0.0005
761 RENAL IMPAIRMENT 39 0.0005
762 ECONOMIC PROBLEM 7 0.0005
763 HAEMORRHAGE 48 0.0005
764 LOCAL SWELLING 8 0.0005
765 IMPAIRED HEALING 15 0.0005
766 ANHEDONIA 12 0.0005
767 WHEEZING 27 0.0005
768 COLD SWEAT 8 0.0005
769 INFUSION RELATED REACTION 30 0.0005
770 DRUG ERUPTION 8 0.0005
771 FOOT DEFORMITY 5 0.0005
772 HEPATOTOXICITY 10 0.0004
773 GAIT INABILITY 15 0.0004
774 CEREBRAL HAEMORRHAGE 16 0.0004
775 ELECTROCARDIOGRAM QT PROLONGED 16 0.0004
776 FREQUENT BOWEL MOVEMENTS 12 0.0004
777 BODY TEMPERATURE INCREASED 9 0.0004
778 PALLOR 12 0.0004
779 LOWER RESPIRATORY TRACT INFECTION 20 0.0004
780 ABSCESS 7 0.0004
781 CHOLECYSTECTOMY 5 0.0004
782 PRODUCT USE ISSUE 82 0.0004
783 ABDOMINAL PAIN LOWER 11 0.0004
784 HYPERHIDROSIS 56 0.0004
785 ERYTHEMA 89 0.0004
786 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 78 0.0004
787 HUNGER 6 0.0004
788 BACK DISORDER 7 0.0004
789 AGRANULOCYTOSIS 8 0.0004
790 BACTERIAL INFECTION 8 0.0004
791 CARDIAC DISORDER 40 0.0004
792 FEELING HOT 26 0.0004
793 URTICARIA 71 0.0004
794 FOOT FRACTURE 8 0.0004
795 CHRONIC KIDNEY DISEASE 32 0.0004
796 IRRITABLE BOWEL SYNDROME 9 0.0004
797 PARALYSIS 6 0.0004
798 SEROTONIN SYNDROME 8 0.0004
799 PRURITUS GENERALISED 9 0.0004
800 PARAESTHESIA ORAL 6 0.0004
801 MENTAL IMPAIRMENT 10 0.0004
802 NO THERAPEUTIC RESPONSE 5 0.0004
803 CEREBRAL INFARCTION 10 0.0004
804 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
805 OSTEONECROSIS OF JAW 10 0.0004
806 ACTIVITIES OF DAILY LIVING IMPAIRED 8 0.0004
807 WEIGHT INCREASED 90 0.0004
808 MUSCULOSKELETAL STIFFNESS 35 0.0004
809 BONE LOSS 6 0.0004
810 HEPATIC FAILURE 12 0.0004
811 MUSCLE ATROPHY 5 0.0004
812 DEMENTIA 11 0.0004
813 SYNOVITIS 7 0.0004
814 ANKLE FRACTURE 6 0.0004
815 TOOTH LOSS 8 0.0004
816 PELVIC PAIN 7 0.0004
817 THERAPY PARTIAL RESPONDER 6 0.0004
818 END STAGE RENAL DISEASE 7 0.0004
819 ROAD TRAFFIC ACCIDENT 16 0.0004
820 BLOOD CREATINE PHOSPHOKINASE INCREASED 11 0.0004
821 SEIZURE 44 0.0004
822 HEAD INJURY 12 0.0004
823 BLOOD GLUCOSE ABNORMAL 7 0.0004
824 THERAPY NON-RESPONDER 17 0.0004
825 BLOOD GLUCOSE INCREASED 71 0.0004
826 HEPATIC FUNCTION ABNORMAL 14 0.0004
827 JOINT INJURY 8 0.0004
828 PHOTOPHOBIA 7 0.0004
829 PAIN OF SKIN 10 0.0004
830 SKIN IRRITATION 17 0.0004
831 THERAPY CESSATION 19 0.0004
832 ACNE 28 0.0004
833 FEELING JITTERY 7 0.0004
834 INTENTIONAL PRODUCT USE ISSUE 32 0.0004
835 PULMONARY FIBROSIS 7 0.0004
836 FLUSHING 37 0.0004
837 CENTRAL NERVOUS SYSTEM LESION 5 0.0004
838 GENERAL PHYSICAL HEALTH DETERIORATION 42 0.0004
839 RHEUMATOID ARTHRITIS 41 0.0004
840 DISCOMFORT 22 0.0004
841 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
842 CHOKING 7 0.0004
843 ORAL HERPES 7 0.0004
844 TYPE 2 DIABETES MELLITUS 12 0.0004
845 FACE OEDEMA 6 0.0004
846 ACCIDENTAL OVERDOSE 13 0.0004
847 ANGER 12 0.0004
848 EYE PAIN 20 0.0004
849 HEPATITIS 9 0.0004
850 TINNITUS 16 0.0003
851 ADVERSE EVENT 32 0.0003
852 MUSCLE TWITCHING 8 0.0003
853 EMOTIONAL DISTRESS 42 0.0003
854 ANOSMIA 5 0.0003
855 NERVOUSNESS 18 0.0003
856 APATHY 5 0.0003
857 HEART RATE DECREASED 12 0.0003
858 HEAD DISCOMFORT 6 0.0003
859 CARDIO-RESPIRATORY ARREST 14 0.0003
860 MOBILITY DECREASED 24 0.0003
861 BLOOD GLUCOSE DECREASED 16 0.0003
862 FIBROMYALGIA 8 0.0003
863 DRUG INTERACTION 52 0.0003
864 HIP ARTHROPLASTY 5 0.0003
865 HYPERSENSITIVITY 60 0.0003
866 MIDDLE INSOMNIA 6 0.0003
867 BRADYCARDIA 17 0.0003
868 NERVOUS SYSTEM DISORDER 10 0.0003
869 DYSKINESIA 13 0.0003
870 DRUG-INDUCED LIVER INJURY 10 0.0003
871 PANCREATITIS ACUTE 7 0.0003
872 OSTEONECROSIS 10 0.0003
873 SHOCK 7 0.0003
874 RECTAL HAEMORRHAGE 13 0.0003
875 DRUG LEVEL INCREASED 5 0.0003
876 VISUAL ACUITY REDUCED 10 0.0003
877 LIP SWELLING 10 0.0003
878 EYE PRURITUS 10 0.0003
879 THROAT TIGHTNESS 8 0.0003
880 SKIN BURNING SENSATION 21 0.0003
881 INFLAMMATION 15 0.0003
882 DIABETES MELLITUS 22 0.0003
883 PROCEDURAL PAIN 8 0.0003
884 RHABDOMYOLYSIS 12 0.0003
885 NEUROTOXICITY 5 0.0003
886 MOUTH ULCERATION 6 0.0003
887 INJURY 20 0.0003
888 NEPHROLITHIASIS 13 0.0003
889 ABASIA 7 0.0003
890 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
891 IMPAIRED WORK ABILITY 6 0.0003
892 MOVEMENT DISORDER 9 0.0003
893 DEPRESSED LEVEL OF CONSCIOUSNESS 11 0.0003
894 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
895 CRYING 10 0.0003
896 SURGERY 16 0.0003
897 AGITATION 20 0.0003
898 GAMMA-GLUTAMYLTRANSFERASE INCREASED 6 0.0003
899 CARDIAC ARREST 22 0.0003
900 CORONARY ARTERY DISEASE 8 0.0003
901 FRACTURE 5 0.0003
902 MUSCULOSKELETAL DISORDER 5 0.0003
903 PRODUCT USE IN UNAPPROVED INDICATION 64 0.0003
904 ASTHMA 29 0.0003
905 SWOLLEN TONGUE 8 0.0003
906 ANAPHYLACTIC REACTION 14 0.0003
907 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 12 0.0002
908 MULTIPLE ORGAN DYSFUNCTION SYNDROME 7 0.0002
909 PANIC ATTACK 9 0.0002
910 UNDERDOSE 18 0.0002
911 THERAPEUTIC PRODUCT EFFECT DECREASED 11 0.0002
912 CONVULSION 14 0.0002
913 MYOCARDIAL INFARCTION 42 0.0002
914 GASTRIC CANCER 6 0.0002
915 CARDIAC FAILURE 19 0.0002
916 OCULAR HYPERAEMIA 11 0.0002
917 RENAL CANCER 11 0.0002
918 ILL-DEFINED DISORDER 14 0.0002
919 INJECTION SITE RASH 7 0.0002
920 EMOTIONAL DISORDER 7 0.0002
921 CONDITION AGGRAVATED 69 0.0002
922 ANGIOEDEMA 10 0.0002
923 EYE IRRITATION 13 0.0002
924 BONE DENSITY DECREASED 7 0.0002
925 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
926 PRODUCT AVAILABILITY ISSUE 5 0.0002
927 RESPIRATORY ARREST 6 0.0002
928 ARTHROPATHY 12 0.0002
929 DIABETIC KETOACIDOSIS 5 0.0002
930 HEPATIC CANCER 5 0.0002
931 PSORIASIS 27 0.0002
932 DRUG EXPOSURE DURING PREGNANCY 7 0.0002
933 DRUG DOSE OMISSION 34 0.0002
934 BREAST CANCER 19 0.0002
935 COLITIS ULCERATIVE 9 0.0002
936 GLYCOSYLATED HAEMOGLOBIN INCREASED 5 0.0002
937 METABOLIC ACIDOSIS 6 0.0002
938 SUICIDAL IDEATION 17 0.0002
939 HYPOGLYCAEMIA 9 0.0002
940 VAGINAL HAEMORRHAGE 8 0.0002
941 DEVICE DISLOCATION 8 0.0002
942 EYE DISORDER 6 0.0002
943 THERAPEUTIC RESPONSE DECREASED 11 0.0002
944 DRUG INEFFECTIVE 232 0.0002
945 NIGHTMARE 6 0.0002
946 EXTRA DOSE ADMINISTERED 7 0.0002
947 ECZEMA 9 0.0002
948 SYSTEMIC LUPUS ERYTHEMATOSUS 6 0.0002
949 ARRHYTHMIA 8 0.0002
950 OESOPHAGEAL CARCINOMA 5 0.0002
951 WITHDRAWAL SYNDROME 7 0.0002
952 IRRITABILITY 10 0.0002
953 PREMATURE BABY 5 0.0002
954 C-REACTIVE PROTEIN INCREASED 6 0.0002
955 TREATMENT NONCOMPLIANCE 9 0.0002
956 ABNORMAL BEHAVIOUR 6 0.0002
957 PROSTATE CANCER 12 0.0001
958 BLINDNESS 6 0.0001
959 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
960 DEVICE USE ERROR 5 0.0001
961 INCORRECT DOSE ADMINISTERED 32 0.0001
962 AGGRESSION 7 0.0001
963 TOXICITY TO VARIOUS AGENTS 23 0.0001
964 TREATMENT FAILURE 11 0.0001
965 DEVICE MALFUNCTION 9 0.0001
966 NO ADVERSE EVENT 23 0.0001
967 COMA 6 0.0001
968 MULTIPLE SCLEROSIS 6 0.0001
969 PRODUCT SUBSTITUTION ISSUE 7 0.0001
970 BLADDER CANCER 7 0.0001
971 DEVICE LEAKAGE 5 0.0001
972 MENTAL DISORDER 5 0.0001
973 INTENTIONAL PRODUCT MISUSE 10 0.0001
974 EXPOSURE DURING PREGNANCY 7 0.0001
975 MATERNAL EXPOSURE DURING PREGNANCY 10 0.0001
976 FOETAL EXPOSURE DURING PREGNANCY 9 0.0001
977 COMPLETED SUICIDE 9 0.0001
978 DISEASE RECURRENCE 5 0.0001
979 INJECTION SITE ERYTHEMA 13 0.0001
980 INJECTION SITE PRURITUS 7 0.0001
981 DERMATITIS ATOPIC 5 0.0001
982 DRUG WITHDRAWAL SYNDROME 8 0.0001
983 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
984 DEVICE ISSUE 7 0.0001
985 INTENTIONAL OVERDOSE 5 0.0001
986 INJECTION SITE BRUISING 6 0.0001
987 INJECTION SITE HAEMORRHAGE 6 0.0001
988 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
989 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 13 0.0001
990 OVERDOSE 13 0.0001
991 INJECTION SITE PAIN 16 0.0001
992 DRUG DEPENDENCE 7 0.0000